DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 189 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $208,000 | -63.2% | 22,481 | +45.8% | 0.00% | -50.0% |
Q2 2021 | $565,000 | +124.2% | 15,422 | +175.4% | 0.00% | 0.0% |
Q1 2021 | $252,000 | -73.4% | 5,600 | -66.3% | 0.00% | -50.0% |
Q4 2020 | $947,000 | -56.3% | 16,600 | -60.7% | 0.00% | -63.6% |
Q3 2020 | $2,166,000 | +425.7% | 42,228 | +512.0% | 0.01% | +450.0% |
Q2 2020 | $412,000 | – | 6,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |